TG Therapeutics, Inc. (TGTX)

Nasdaq Health Care Biotechnology S&P SmallCap 600

$59.83

+1.85 (+3.18%)

Close of Nov 06, 2026 · end-of-day data

Source: TG Therapeutics, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 02, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$152.00K	$152.00K	$152.00K	$152.00K	$152.00K	$6.69M	$2.79M	$233.66M	$329.00M	$616.29M
Cost of revenue	—	—	—	—	—	$790.00K	$265.00K	$14.13M	$38.49M	$100.71M
Gross profit	—	—	—	—	—	$5.90M	$2.52M	$219.53M	$290.52M	$515.57M
Research & development	$69.23M	$102.53M	$159.39M	$154.18M	$165.90M	$222.58M	$125.35M	$76.19M	$94.29M	$160.22M
Selling, general & admin	—	—	—	$15.03M	$107.85M	$128.09M	$95.48M	$122.71M	$154.30M	$232.03M
Operating income	-$78.97M	-$118.71M	-$174.40M	-$169.06M	-$273.59M	-$344.77M	-$218.32M	$20.63M	$41.93M	$123.32M
Interest expense	—	$845.00K	$877.00K	$5.29M	$6.33M	$5.64M	$10.19M	$12.62M	$24.03M	$26.73M
Pre-tax income	-$78.25M	-$118.48K	-$173.48K	-$172.87K	-$279.38K	-$348.10M	-$223.81M	$13.06M	$25.59M	$107.39M
Income tax	$0	$0	$0	$0	$0	$0	$0	$390.00K	$2.21M	-$339.79M
Net income	-$78.25M	-$118.48M	-$173.48M	-$172.87M	-$279.38M	-$348.10M	-$223.81M	$12.67M	$23.38M	$447.18M
EBITDA	-$78.91M	-$118.63M	-$174.31M	-$168.96M	-$273.44M	-$344.49M	-$218.01M	$20.84M	$42.00M	$123.38M
EPS (basic)	$-1.60	$-1.91	$-2.30	$-1.96	$-2.42	$-2.63	$-1.65	$0.09	$0.16	$3.10
EPS (diluted)	$-1.60	$-1.91	$-2.30	$-1.96	$-2.42	$-2.63	$-1.65	$0.09	$0.15	$2.77
Diluted shares	49.04M	62.07M	75.47M	88.37M	115.33M	132.22M	135.41M	148.51M	160.34M	161.41M
Gross margin	—	—	—	—	—	88.2%	90.5%	94.0%	88.3%	83.7%
Operating margin	-51953.3%	-78100.0%	-114736.8%	-111220.4%	-179996.1%	-5154.3%	-7839.0%	8.8%	12.7%	20.0%
Net margin	-51482.2%	-77944.7%	-114132.9%	-113730.9%	-183803.3%	-5204.1%	-8036.3%	5.4%	7.1%	72.6%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$25.03M	$56.72M	$41.96M	$112.64M	$553.44M	$298.89M	$102.30M	$92.93M	$179.89M	$79.15M
Short-term investments	$19.85M	$28.00M	$26.94M	$27.80M	$51.99M	$15.88M	$59.37M	$124.58M	$131.11M	$62.82M
Receivables	—	—	—	—	—	$1.39M	$0	$51.09M	$129.19M	$305.63M
Inventory	—	—	—	—	—	—	$0	$39.82M	$110.46M	$125.59M
Total current assets	$50.86M	$93.32M	$79.03M	$149.15M	$611.74M	$330.96M	$168.27M	$317.94M	$566.36M	$630.76M
Goodwill	$799.39K	$799.00K	$799.00K	$799.00K	$799.00K	$799.00K	$799.00K	$799.00K	—	—
Total assets	$54.78M	$97.38M	$83.62M	$163.01M	$625.64M	$379.63M	$193.57M	$329.59M	$577.69M	$1.06B
Total current liabilities	$16.88M	$27.96M	$38.85M	$84.45M	$87.55M	$65.38M	$53.20M	$53.72M	$90.68M	$153.76M
Short-term debt	—	—	—	$0	$22.18M	$975.00K	$0	—	—	—
Long-term debt	—	—	$0	$28.97M	$7.72M	$66.79M	$71.14M	$100.12M	$244.43M	$245.65M
Total debt	—	—	$0	$28.97M	$29.89M	$67.76M	$71.14M	$100.12M	$244.43M	$245.65M
Total liabilities	$18.91M	$30.39M	$59.58M	$124.40M	$106.29M	$142.48M	$134.99M	$169.09M	$355.33M	$415.23M
Shareholders' equity	$35.87M	$66.99M	$24.04M	$38.62M	$519.35M	$237.15M	$58.59M	$160.50M	$222.36M	$648.02M

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$61.59M	-$93.76M	-$128.93M	-$132.81M	-$214.51M	-$295.63M	-$176.17M	-$31.41M	-$40.52M	-$24.77M
Capital expenditures	$344.00K	$2.00K	$90.00K	$131.00K	$357.00K	$401.00K	$14.00K	$0	$45.00K	$214.00K
Free cash flow	-$61.93M	-$93.76M	-$129.01M	-$132.94M	-$214.86M	-$296.04M	-$176.18M	-$31.41M	-$40.56M	-$24.99M
Investing cash flow	$26.55M	-$8.21M	$1.18M	-$718.00K	-$24.51M	-$332.00K	-$20.01M	-$50.65M	-$1.04M	$13.80M
Financing cash flow	$5.02M	$133.66M	$113.64M	$204.21M	$679.83M	$41.42M	-$391.00K	$72.70M	$128.53M	-$89.73M
Stock-based compensation	$7.50M	$15.90M	$12.89M	$11.34M	$80.29M	$61.27M	$44.66M	$37.93M	$42.54M	$64.67M
Depreciation & amortization	$63.00K	$82.00K	$88.00K	$100.00K	$158.00K	$282.00K	$303.00K	$211.00K	$68.00K	$59.00K

Income statement

quarters · USD

Quarter ended	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$165.81M	$43.97M	$63.47M	$73.47M	$83.88M	$108.19M	$120.86M	$141.15M	$161.71M	$192.57M	$204.92M	$240.34M
Cost of revenue	$3.51M	$7.85M	$5.44M	$8.30M	$9.34M	$15.40M	$15.54M	$18.94M	$28.09M	$38.14M	$33.51M	$41.19M
Gross profit	$162.31M	$36.12M	$58.03M	$65.16M	$74.54M	$92.79M	$105.31M	$122.21M	$133.62M	$154.43M	$171.41M	$199.14M
Research & development	$14.75M	$17.45M	$32.72M	$17.56M	$20.14M	$23.87M	$46.36M	$31.78M	$40.88M	$41.19M	$48.40M	$95.34M
Selling, general & admin	$32.77M	$31.15M	$34.58M	$38.79M	$41.97M	$38.96M	$50.33M	$55.59M	$63.37M	$62.74M	$88.22M	$82.13M
Operating income	$114.78M	-$12.48M	-$9.27M	$8.82M	$12.43M	$29.95M	$8.62M	$34.84M	$29.36M	$50.49M	$34.80M	$21.67M
Interest expense	$3.71M	$2.43M	$2.29M	$3.98M	$10.83M	$7.06M	$6.76M	$6.72M	$6.72M	$6.53M	$7.67M	$16.57M
Pre-tax income	$113.93M	-$14.03M	-$10.68M	$6.55M	$4.27M	$25.45M	$5.47M	$30.92M	$25.91M	$45.09M	$20.36M	$10.23M
Income tax	$0	$390.00K	$29.00K	-$328.00K	$388.00K	$2.12M	$408.00K	$2.73M	-$364.99M	$22.06M	$586.00K	$2.45M
Net income	$113.93M	-$14.42M	-$10.71M	$6.88M	$3.88M	$23.33M	$5.06M	$28.19M	$390.89M	$23.04M	$19.78M	$7.78M
EBITDA	$114.86M	-$12.45M	-$9.24M	$8.84M	$12.45M	$29.96M	$8.63M	$34.86M	$29.38M	$50.52M	$34.83M	$21.73M
EPS (basic)	$0.80	$-0.10	$-0.07	$0.05	$0.03	$0.16	$0.03	$0.19	$2.69	$0.20	$0.14	$0.05
EPS (diluted)	$0.73	$-0.10	$-0.07	$0.04	$0.02	$0.15	$0.03	$0.17	$2.43	$0.15	$0.12	$0.05
Diluted shares	155.87M	2.56M	146.21M	159.42M	160.71M	-30.88K	162.77M	162.56M	161.00M	-689.63K	160.06M	157.28M
Gross margin	97.9%	82.1%	91.4%	88.7%	88.9%	85.8%	87.1%	86.6%	82.6%	80.2%	83.6%	82.9%
Operating margin	69.2%	-28.4%	-14.6%	12.0%	14.8%	27.7%	7.1%	24.7%	18.2%	26.2%	17.0%	9.0%
Net margin	68.7%	-32.8%	-16.9%	9.4%	4.6%	21.6%	4.2%	20.0%	241.7%	12.0%	9.7%	3.2%

Balance sheet

quarters · USD

Quarter ended	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Cash & equivalents	$150.90M	$92.93M	$75.48M	$82.91M	$195.82M	$179.89M	$132.14M	$129.13M	$74.08M	$79.15M	$442.21M	$482.57M
Short-term investments	$78.26M	$124.58M	$134.31M	$134.34M	$145.22M	$131.11M	$144.10M	$122.74M	$57.50M	$62.82M	$72.22M	$69.67M
Receivables	$39.32M	$51.09M	$64.98M	$83.61M	$115.73M	$129.19M	$190.12M	$231.52M	$265.38M	$305.63M	$392.05M	$401.56M
Inventory	$33.55M	$39.82M	$77.72M	$81.24M	$84.67M	$110.46M	$157.76M	$155.20M	$146.95M	$125.59M	$129.03M	$147.97M
Total current assets	$319.11M	$317.94M	$360.58M	$389.15M	$574.07M	$566.36M	$644.51M	$663.96M	$599.76M	$630.76M	$1.09B	$1.15B
Goodwill	$799.00K	$799.00K	$799.00K	—	—	—	—	—	—	—	—	—
Total assets	$331.07M	$329.59M	$373.32M	$401.21M	$586.01M	$577.69M	$656.69M	$702.61M	$1.03B	$1.06B	$1.53B	$1.64B
Total current liabilities	$57.68M	$53.72M	$99.68M	$108.66M	$125.11M	$90.68M	$160.21M	$171.89M	$156.81M	$153.76M	$187.11M	$268.49M
Short-term debt	$0	—	—	—	—	—	—	—	—	—	—	—
Long-term debt	$98.91M	$100.12M	$101.33M	$102.54M	$244.16M	$244.43M	$244.73M	$245.04M	$245.34M	$245.65M	$745.14M	$745.39M
Total debt	$98.91M	$100.12M	$101.33M	$102.54M	$244.16M	$244.43M	$244.73M	$245.04M	$245.34M	$245.65M	$745.14M	$745.39M
Total liabilities	$166.30M	$169.09M	$213.21M	$223.64M	$393.86M	$355.33M	$419.40M	$426.18M	$417.81M	$415.23M	$945.71M	$1.04B
Shareholders' equity	$164.77M	$160.50M	$160.11M	$177.57M	$192.16M	$222.36M	$237.29M	$276.43M	$607.22M	$648.02M	$583.13M	$604.08M

Cash flow

quarters · USD

Quarter ended	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Operating cash flow	$83.70M	-$13.21M	-$8.21M	$5.54M	-$12.21M	-$25.64M	-$28.71M	$7.44M	-$23.15M	$19.66M	-$17.89M	$39.26M
Capital expenditures	—	$0	$0	$0	$24.00K	$21.00K	$25.00K	$42.00K	$80.00K	$67.00K	$51.00K	$293.00K
Free cash flow	$83.70M	-$13.21M	-$8.21M	$5.54M	-$12.23M	-$25.66M	-$28.74M	$7.39M	-$23.23M	$19.59M	-$17.95M	$38.97M
Investing cash flow	-$30.23M	-$44.76M	-$9.26M	$1.76M	-$9.33M	$15.79M	-$12.93M	-$3.99M	$46.36M	-$15.64M	-$9.86M	$1.03M
Financing cash flow	$421.00K	-$1.00K	$10.00K	$135.00K	$134.45M	-$6.07M	-$6.10M	-$6.44M	-$78.24M	$1.06M	$390.83M	$85.00K
Stock-based compensation	$9.18M	$9.38M	$9.34M	$9.48M	$11.77M	$11.95M	$14.97M	$16.36M	$17.69M	$15.65M	$19.95M	$27.88M
Depreciation & amortization	$73.00K	$38.00K	$29.00K	$19.00K	$11.00K	$9.00K	$8.00K	$13.00K	$17.00K	$21.00K	$32.00K	$53.00K

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.